Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC25A12 |
| Upstream (Parents) |
|---|
| (<<) KIAA1199 → SLC25A12 |
| (<<) SPOCK1 → SLC25A12 |
| (<<) NOTCH3 → SLC25A12 |
| (<<) ZBED4 → SLC25A12 |
| (<<) CIZ1 → SLC25A12 |
| Downstream (Children) |
|---|
| SLC25A12 → KIAA1199 (>>) |
| SLC25A12 → LRP1B (>>) |
| SLC25A12 → CCL24 (>>) |
| SLC25A12 → OSR2 (>>) |
| SLC25A12 → PAQR6 (>>) |
| SLC25A12 → KIAA1661 (>>) |
| SLC25A12 → LGALS13 (>>) |
| SLC25A12 → SNRNP200 (>>) |
| SLC25A12 → SOD3 (>>) |
| SLC25A12 → RGS6 (>>) |
| SLC25A12 → KIAA0509 (>>) |
| SLC25A12 → TEC (>>) |
| SLC25A12 → FRMPD4 (>>) |
| SLC25A12 → MAST2 (>>) |
| SLC25A12 → ARHGEF10 (>>) |
| SLC25A12 → MAP4K5 (>>) |
| SLC25A12 → B3GNTL1 (>>) |
| SLC25A12 → STXBP1 (>>) |
| SLC25A12 → FAM86C (>>) |
| SLC25A12 → SIN3B (>>) |
| SLC25A12 → MYBL1 (>>) |
| SLC25A12 → NEK11 (>>) |
| SLC25A12 → ZBED4 (>>) |
| SLC25A12 → CIZ1 (>>) |
| SLC25A12 → WLS (>>) |
| SLC25A12 → WFS1 (>>) |
